ArticleClinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology2014
The R-Stereoisomer of Ketamine as an Alternative for Ketamine for Treatment-resistant Major Depression.
Article in Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 40 citations in OpenAlex.
- Ketamine and its two enantiomers in anesthesiology and psychiatry: A historical review and future directions.Journal of anesthesia and translational medicine · 2024Review
- Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor.Molecular psychiatry · 2022Review
- Brain NMDA Receptors in Schizophrenia and Depression.Biomolecules · 2020Review
- Rapid-acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective.Psychiatry and clinical neurosciences · 2019Review
- Abnormalities in Inflammatory Cytokines Confer Susceptible to Chronic Neuropathic Pain-related Anhedonia in a Rat Model of Spared Nerve Injury.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2019Article
- Synthesis of Structurally Diverse N-Substituted Quaternary-Carbon-Containing Small Molecules from α,α-Disubstituted Propargyl Amino Esters.Chemistry (Weinheim an der Bergstrasse, Germany) · 2018Article
- Reduction of dopamine DEuropean archives of psychiatry and clinical neuroscience · 2017Article
- Analysis of print news media framing of ketamine treatment in the United States and Canada from 2000 to 2015.PloS one · 2017Article
- New Treatment Strategies of Depression: Based on Mechanisms Related to Neuroplasticity.Neural plasticity · 2017Review
- Antidepressant Effects of (+)-MK-801 and (-)-MK-801 in the Social Defeat Stress Model.The international journal of neuropsychopharmacology · 2016Article
- Comparison of R-ketamine and rapastinel antidepressant effects in the social defeat stress model of depression.Psychopharmacology · 2016Article
- Brain-derived Neurotrophic Factor (BDNF)-TrkB Signaling in Inflammation-related Depression and Potential Therapeutic Targets.Current neuropharmacology · 2016Review
- Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression.Psychopharmacology · 2015Article
- BDNF-TrkB signaling in the nucleus accumbens shell of mice has key role in methamphetamine withdrawal symptoms.Translational psychiatry · 2015Article
- R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects.Translational psychiatry · 2015Article
- Combination of Nitrous Oxide with Isoflurane or Scopolamine for Treatment-resistant Major Depression.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2015Article
- Inflammatory biomarkers as differential predictors of antidepressant response.International journal of molecular sciences · 2015Review
- Blood D-serine levels as a predictive biomarker for the rapid antidepressant effects of the NMDA receptor antagonist ketamine.Psychopharmacology · 2014Article
- Rapid antidepressant effects and abuse liability of ketamine.Psychopharmacology · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.